News & Events

Upcoming Events

There are currently no events scheduled.

May
4 May 2017 The Medicines Company to Participate in the Bank of America Merrill Lynch 2017 Health Care Conference
April
26 Apr 2017 The Medicines Company Reports First-Quarter 2017 Financial Results
26 Apr 2017 The Medicines Company and Alnylam Pharmaceuticals Announce Agreement with FDA on Phase III Clinical Program for Inclisiran
17 Apr 2017 The Medicines Company to Present Data at ECCMID 2017 on Infectious Disease Portfolio Including Investigational Antibiotic Meropenem-Vaborbactam
12 Apr 2017 The Medicines Company to Announce First-Quarter 2017 Financial Results on April 26, 2017
March
31 Mar 2017 The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors
30 Mar 2017 The Medicines Company to Present at Needham Healthcare Conference
17 Mar 2017 The Medicines Company and Alnylam Pharmaceuticals Report Positive Final Results from ORION-1 Phase II Study of Inclisiran
14 Mar 2017 The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of Inclisiran at ACC.17
February
28 Feb 2017 The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results
21 Feb 2017 The Medicines Company Announces FDA Filing Acceptance of New Drug Application for Intravenous Antibiotic Carbavance® (meropenem-vaborbactam)
17 Feb 2017 The Medicines Company to Announce Fourth-Quarter and Full-Year 2016 Financial Results on February 28, 2017
January
25 Jan 2017 The Medicines Company to Present Results from ORION-1 Phase 2 Study of Inclisiran at the American College of Cardiology’s 66th Annual Scientific Session
8 Jan 2017 The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)
4 Jan 2017 The Medicines Company to Present at J. P. Morgan Healthcare Conference